Stem cell therapy in multiple sclerosis: a future perspective. (Q48450832)

11 February 2018

editorial

0 references

title

Stem cell therapy in multiple sclerosis: a future perspective. (English)

1 reference

11 February 2018

0 references

Violaine K Harris

1

1 reference

11 February 2018

Saud A Sadiq

series ordinal

2

1 reference

11 February 2018

publication date

1 June 2015

1 reference

11 February 2018

Neurodegenerative disease management

published in

1 reference

11 February 2018

volume

5

1 reference

11 February 2018

issue

3

1 reference

11 February 2018

page(s)

167-170

1 reference

11 February 2018

Defining the risks of mesenchymal stromal cell therapy.

cites work

1 reference

The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group

21 January 2018

1 reference

Randomized placebo-controlled phase II trial of autologous mesenchymal stem cells in multiple sclerosis.

21 January 2018

1 reference

Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study

21 January 2018

1 reference

Analysis of tissues following mesenchymal stromal cell therapy in humans indicates limited long-term engraftment and no ectopic tissue formation.

21 January 2018

1 reference

Multiple administrations of human marrow stromal cells through cerebrospinal fluid prolong survival in a transgenic mouse model of amyotrophic lateral sclerosis.

21 January 2018

1 reference

Human mesenchymal stem cells infiltrate the spinal cord, reduce demyelination, and localize to white matter lesions in experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

Effects of murine and human bone marrow-derived mesenchymal stem cells on cuprizone induced demyelination

21 January 2018

1 reference

Intrathecal baclofen and morphine in multiple sclerosis patients with severe pain and spasticity

21 January 2018

1 reference

Intrathecal methotrexate treatment in multiple sclerosis

21 January 2018

1 reference

Long-term intrathecal baclofen therapy in ambulatory patients with spasticity

21 January 2018

1 reference

Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis

21 January 2018

1 reference

Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study

21 January 2018

1 reference

Characterization of autologous mesenchymal stem cell-derived neural progenitors as a feasible source of stem cells for central nervous system applications in multiple sclerosis

21 January 2018

1 reference

Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing

21 January 2018

1 reference

Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties?

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/NMT.15.6

1 reference

11 February 2018

PubMed ID

26107312

1 reference

11 February 2018